Sarcoma

From the Food and Drug Administration asking pharmaceutical companies to voluntarily recall metformin, a type 2 diabetes medication, as it contains high levels of the cancer-causing contaminant NDMA to an NHL team’s fanbase showing support to a player as he finishes treatment for Ewing sarcoma, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved the first new treatment option for Kaposi sarcoma in more than 20 years.

I'm keeping hope alive that eventually, we'll get through the other side of the COVID-19 pandemic. One day at a time like anything else.

It's pretty clear that I have a lot of work ahead of me after years of devastation from cancer, but lately, I'm taking a new approach.

Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.

The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.

Having loved ones by your side is right up there in importance with any aspect of healing from cancer.

When we talk about stage 4 cancers, a lot of the time we hear about the disease spreading to the bones. It is important for us to understand that this is very different from cancer that originates in the bone.

Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer.

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Where does hope lie when it comes to improving the treatment landscape for rare cancers?

A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.

From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Turalio to treat patients diagnosed with a group of rare, benign tumors.

The Food and Drug Administration granted a priority review to a new drug application for the accelerated approval of tazemetostat to treat metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery.

From today’s top performers and athletes to surprising findings about prostate cancer treatment, here’s what is making headlines in the cancer space this week.

The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.

The New York City chef dreamed of opening her own restaurant.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

Research continues to drive the oncology field.

New clinical trials have oncologists excited about potential new therapies for patients.

Professional snowboarder Bibian Mentel-Spee inspires through her perseverance despite facing multiple bouts with the disease.

Recovery from cancer doesn’t just involve physical health; it often involves overcoming the financial barriers between illness and wellness that make moving forward seem impossible.

Do I really have to wear a prosthesis?

Finding out you have an illness is quite difficult.

Fighting retroperitoneal sarcoma can be like fighting a rare and giant beast.

Cancer not only affects the body, it affects the mind as well.

There are many ways to celebrate the absence of cancer.